Scholarlink

Objective <p>To report medical outcomes and time-related recidivism after extensive cholesteatoma treated with canal wall-down (CWD) mastoidectomy, external ear canal (EEC) reconstruction, tympanoplasty, and S53P4 bioactive-glass mastoid obliteration.</p> Methods <p>Retrospective study of 127 ears with extensive cholesteatoma treated at a tertiary center. Patients were scheduled for annual otoscopic and non-echo-planar DW MRI follow-up for up to 4 years. For each postoperative year, only ears attending that visit and all previous yearly visits were analyzed. Main outcomes were: completely epithelialized, dry ear; tympanic membrane and/or posterior–superior EEC retraction; retraction pocket (RP) cholesteatoma; and residual cholesteatoma on MRI.</p> Results <p>Follow-up attendance declined from 100% (127/127) in year 1 to 67.2% (41/61) in year 4. A dry, epithelialized ear was achieved in 96.9% (123/127). Retraction developed in 33.9% (43/127), with probabilities of 13.4%, 26.4%, 28.9%, and 34.1% at 1, 2, 3, and 4 years, respectively. RP cholesteatoma occurred in 11.8% (15/127) and residual cholesteatoma on MRI in 7.0% (9/127); 23% of retracted ears progressed to RP cholesteatoma. Children ≤ 11 years had higher rates of retraction and RP cholesteatoma.</p> Conclusions <p>Despite counseling on the importance of follow-up, attendance declined over time. CWD mastoidectomy with EEC reconstruction, tympanoplasty, and S53P4 obliteration yielded high long-term dry ear rates in extensive and recurrent cholesteatoma, but complete eradication was not achieved. Younger and re-operated patients were at higher risk of retraction and RP cholesteatoma. Recidivism appeared years after the first surgery, supporting prolonged follow-up. Reporting annual outcome incidence in future studies would enhance understanding of extensive cholesteatoma.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Medical outcomes after canal wall-down mastoidectomy, external ear canal reconstruction, tympanoplasty, and mastoid obliteration for extensive cholesteatoma

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月23日

查看全文
  • Michal Luntz,
  • Keren Hod,
  • Roni Barzilai

摘要

Objective

To report medical outcomes and time-related recidivism after extensive cholesteatoma treated with canal wall-down (CWD) mastoidectomy, external ear canal (EEC) reconstruction, tympanoplasty, and S53P4 bioactive-glass mastoid obliteration.

Methods

Retrospective study of 127 ears with extensive cholesteatoma treated at a tertiary center. Patients were scheduled for annual otoscopic and non-echo-planar DW MRI follow-up for up to 4 years. For each postoperative year, only ears attending that visit and all previous yearly visits were analyzed. Main outcomes were: completely epithelialized, dry ear; tympanic membrane and/or posterior–superior EEC retraction; retraction pocket (RP) cholesteatoma; and residual cholesteatoma on MRI.

Results

Follow-up attendance declined from 100% (127/127) in year 1 to 67.2% (41/61) in year 4. A dry, epithelialized ear was achieved in 96.9% (123/127). Retraction developed in 33.9% (43/127), with probabilities of 13.4%, 26.4%, 28.9%, and 34.1% at 1, 2, 3, and 4 years, respectively. RP cholesteatoma occurred in 11.8% (15/127) and residual cholesteatoma on MRI in 7.0% (9/127); 23% of retracted ears progressed to RP cholesteatoma. Children ≤ 11 years had higher rates of retraction and RP cholesteatoma.

Conclusions

Despite counseling on the importance of follow-up, attendance declined over time. CWD mastoidectomy with EEC reconstruction, tympanoplasty, and S53P4 obliteration yielded high long-term dry ear rates in extensive and recurrent cholesteatoma, but complete eradication was not achieved. Younger and re-operated patients were at higher risk of retraction and RP cholesteatoma. Recidivism appeared years after the first surgery, supporting prolonged follow-up. Reporting annual outcome incidence in future studies would enhance understanding of extensive cholesteatoma.